Apolipoprotein A-IV as a novel gene associated with polycystic ovary syndrome

International Journal of Molecular Medicine

Volumn 31, Issue 3, 2013, Pages 707-716

  Kim, Yong Soo ^a   Gu, Bon Hee ^a   Choi, Bum Chae ^b,c   Kim, Myung Sun ^a   Song, Sangjin ^c   Yun, Ji Hyun ^a   Chung, Mi Kyung ^a   Choi, Cheol Hee ^b   Baek, Kwang Hyun ^a  

^a CHA University   (South Korea)

^b Chosun University College of Medicine   (South Korea)

^c Department of Obstetrics and Gynecology   (South Korea)

Author keywords

Apolipoprotein A IV; Follicular fluid; Single nucleotide polymorphism; Two dimensional gel electrophoresis

Indexed keywords

ALPHA 1 B GLYCOPROTEIN; ANTITHROMBIN; APOLIPOPROTEIN A4; CYTOKERATIN 9; ESTRADIOL; FIBRINOGEN; FIBRINOGEN GAMMA; FOLLITROPIN; GLYCOPROTEIN B; KININOGEN; KININOGEN I; LUTEINIZING HORMONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FUNCTIONAL PROTEOMICS; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; OVARY FOLLICLE FLUID; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING;

ADULT; ANTITHROMBINS; APOLIPOPROTEINS A; FEMALE; FIBRINOGENS, ABNORMAL; FOLLICULAR FLUID; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULINS; KERATIN-9; KININOGENS; OVARIAN FOLLICLE; POLYCYSTIC OVARY SYNDROME; PROTEOMICS;

EID: 84873203279     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1250     Document Type: Article

References (48)

1. Goodarzi MO, Dumesic DA, Chazenbalk G and Azziz R: Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rew Endocrinol 7: 219-231, 2011.
2. Hart R, Hickey M and Franks S: Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 18: 671-683, 2004.
3. Pasquali R, Stener-Victorin E, Yildiz BO, Duleba AJ, Hoeger K, Mason H, Homburg R, Hickey T, Franks S, Tapanainen JS, et al: PCOS Forum: research in polycystic ovary syndrome today and tomorrow. Clin Endocrinol (Oxf) 74: 424-433, 2011.
4. Dumesic DA, Abbott DH and Padmanabhan V: Polycystic ovary syndrome and its developmental origins. Rev Endocr Metab Disord 8: 127-141, 2007.
5. Hourvitz A, Kuwahara A, Hennebold JD, Tavares AB, Negishi H, Lee TH, Erickson GF and Adashi EY: The regulated expression of the pregnancy-associated plasma protein-A in the rodent ovary: a proposed role in the development of dominant follicles and of corpora lutea. Endocrinology 143: 1833-1844, 2002.
6. Teixeira Filho FL, Baracat EC, Lee TH, Suh CS, Matsui M, Chang RJ, Shimasaki S and Erickson GF: Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome. J Clin Endocrinol Metab 87: 1337-1344, 2002.
7. Munir I, Yen HW, Baruth T, Tarkowki R, Azziz R, Magoffin DA and Jakimiuk AJ: Resistin stimulation of 17alpha-hydroxylase activity in ovarian theca cells in vitro: relevance to polycystic ovary syndrome. J Clin Endocrinol Metab 90: 4852-4857, 2005.
8. Wickenheisser JK, Nelson-Degrave VL and McAllister JM: Dysregulation of cytochrome P450 17alpha-hydroxylase messenger ribonucleic acid stability in theca cells isolated from women with polycystic ovary syndrome. J Clin Endocrinol Metab 90: 1720-1727, 2005.
9. Goodarzi MO, Jones MR, Chen YD and Azziz R: First evidence of genetic association between AKT2 and polycystic ovary syndrome. Diabetes Care 31: 2284-2287, 2008.
10. Kim JJ, Choi YM, Hong MA, Hwang SS, Yoon SH, Chae SJ, Jee BC, Ku SY, Kim JG and Moon SY: Phosphatidylinositol 3-kinase p85alpha regulatory subunit gene Met326Ile polymorphism in women with polycystic ovary syndrome. Hum Reprod 24: 1184-1190, 2009.
11. Gu BH and Baek KH: Pro12Ala and His447His polymorphisms of PPAR-gamma are associated with polycystic ovary syndrome. Reprod Biomed Online 18: 644-650, 2009.
12. Choi SW, Gu BH, Ramakrishna S, Park JM and Baek KH: Association between a single nucleotide polymorphism in MTHFR gene and polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 145: 85-88, 2009.
13. Fortune JE: Ovarian follicular growth and development in mammals. Biol Reprod 50: 225-232, 1994.
14. Chiu PC, Koistinen R, Koistinen H, Seppala M, Lee KF and Yeung WS: Zona-binding inhibitory factor-1 from human follicular fluid is an isoform of glycodelin. Biol Reprod 69: 365-372, 2003.
15. Coy P, Gadea J, Romar R, Matas C and Garcia E: Effect of in vitro fertilization medium on the acrosome reaction, cortical reaction, zona pellucida hardening and in vitro development in pigs. Reproduction 124: 279-288, 2002.
16. Yao Y, Ho P and Yeung WS: Effects of human follicular fluid on the capacitation and motility of human spermatozoa. Fertil Steril 73: 680-686, 2002.
17. Wang TH, Chang CL, Wu HM, Chiu YM, Chen CK and Wang HS: Insulin-like growth factor-II (IGF-II), IGF-binding protein-3 (IGFBP-3), and IGFBP-4 in follicular fluid are associated with oocyte maturation and embryo development. Fertil Steril 86: 1392-1401, 2006.
18. Wu YT, Tang L, Cai J, Lu XE, Xu J, Zhu XM, Luo Q and Huang HF: High bone morphogenetic protein-15 level in follicular fluid is associated with high quality oocyte and subsequent embryonic development. Hum Reprod 22: 1526-1531, 2007.
19. Rosen MP, Zamah AM, Shen S, Dobson AT, McCulloch CE, Rinaudo PF, Lamb JD and Cedars MI: The effect of follicular fluid hormones on oocyte recovery after ovarian stimulation: FSH level predicts oocyte recovery. Reprod Biol Endocrinol 7: 35, 2009.
20. Kim YS, Kim MS, Lee SH, Choi BC, Lim JM, Cha KY and Baek KH: Proteomic analysis of recurrent pregnancy loss: Identification of an inadequately expressed set of proteins in human follicular fluid. Proteomics 6: 3445-3454, 2006.
21. Kim MS, Gu BH, Song S, Choi BC, Cha DH and Baek KH: ITI-H4, as a biomarker in the serum of recurrent pregnancy loss (RPL) patients. Mol Biosyst 7: 1430-1440, 2011.
22. Atiomo W, Khalid S, Parameshweran S, Houda M and Layfield R: Proteomic biomarkers for the diagnosis and risk stratification of polycystic ovary syndrome: a systematic review. BJOG 116: 137-143, 2009.
23. Jarkovska K, Martinkova J, Liskova L, Halada P, Moos J, Rezabek K, Gadher SJ and Kovarova H: Proteome mining of human follicular fluid reveals a crucial role of complement cascade and key biological pathways in women undergoing in vitro fertilization. J Proteome Res 9: 1289-1301, 2010.
24. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group: Revised 2003 consensus on diagnostic criteria and long health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19: 41-47, 2004.
25. Gravett MG, Thomas A, Schneider KA, Reddy AP, Dasari S, Jacob T, Lu X, Rodland M, Pereira L, Sadowsky DW, et al: Proteomic analysis of cervical vaginal fluid: identification of novel biomarkers for detection of intra-amniotic infection. J Proteome Res 6: 89-96, 2007.
26. Park JS, Oh KJ, Norwitz ER, Han JS, Choi HJ, Seong HS, Kang YD, Park CW, Kim BJ, Jun JK, et al: Identification of proteomic biomarkers of preeclampsia in amniotic fluid using SELDI-TOF mass spectrometry. Reprod Sci 15: 457-468, 2008.
27. Sadeghi M, Roohafza H, Afshar H, Rajabi F, Ramzani M, Shemirani H and Sarafzadeghan N: Relationship between depression and apolipoproteins A and B: a case-control study. Clinics (Sao Paulo) 66: 113-117, 2011.
28. Ferrer F, Nazih H, Zair Y, Krempf M and Bard JM: Postprandial changes in the distribution of apolipoprotein AIV between apolipoprotein B- and non apolipoprotein B-containing lipoproteins in obese women. Metabolism 52: 1537-1541, 2003.
29. Araki S, Okazaki M and Goto S: Impaired lipid metabolism in aged mice as revealed by fasting-induced expression of apolipoprotein mRNAs in the liver and changes in serum lipids. Gerontology 50: 206-215, 2004.
30. Qin X and Tso P: The role of apolipoprotein AIV on the control of food intake. Curr Drug Targets 6: 145-151, 2005.
31. Whited KL, Lu D, Tso P, Kent Lloyd KC and Raybould HE: Apolipoprotein A-IV is involved in detection of lipid in the rat intestine. J Physiol 569: 949-958, 2005.
32. Culnan DM, Cooney RN, Stanley B and Lynch CJ: Apolipoprotein A-IV, a putative satiety/antiatherogenic factor, rises after gastric bypass. Obesity 17: 46-52, 2009.
33. Ostos MA, Conconi M, Vergnes L, Baroukh N, Ribalta J, Girona J, Caillaud JM, Ochoa A and Zakin MM: Antioxidative and antiatherosclerotic effects of human apolipoprotein A-IV in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 21: 1023-1028, 2001.
34. Broedl UC, Schachinger V, Lingenhel A, Lehrke M, Stark R, Seibold F, Göke B, Kronenberg F, Parhofer KG and Konrad-Zerna A: Apolipoprotein A-IV is an independent predictor of disease activity in patients with inflammatory bowel disease. Inflamm Bowel Dis 13: 391-397, 2007.
35. Remaley AT, Stonik JA, Demosky SJ, Neufeld EB, Bocharov AV, Vishnyakova TG, Eggerman TL, Patterson AP, Duverger NJ, Santamarina-Fojo S, et al: Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. Biochem Biophys Res Commun 280: 818-823, 2001.
36. Stylianou IM, Affourtit JP, Shockley KR, Wilpan RY, Abdi FA, Bhardwaj S, Rollins J, Churchill GA and Paigen B: Applying gene expression, proteomics and single-nucleotide polymorphism analysis for complex trait gene identification. Genetics 178: 1795-1805, 2008.
37. Jin EH, Shim SC, Kim HG, Chae SC and Chung HT: Polymorphisms of COTL1 gene identified by proteomic approach and their association with autoimmune disorders. Exp Mol Med 41: 354-361, 2009.
38. Weinberg RB: Apolipoprotein A-IV polymorphisms and diet-gene interactions. Curr Opin Lipidol 13: 125-134, 2002.
39. Vincent S, Planells R, Defoort C, Bernard MC, Gerber M, Prudhomme J, Vague P and Lairon D: Genetic polymorphisms and lipoprotein responses to diets. Proc Nutr Soc 61: 427-434, 2002.
40. Bai H, Liu R, Liu Y, Saku K and Liu BW: Distribution and effect of apo A-IV genotype on plasma lipid and apolipoprotein levels in a Chinese population. Acta Cardiol 63: 315-322, 2008.
41. Heilbronn LK, Noakes M, Morris AM, Kind KL and Clifton PM: 360His polymorphism of the apolipoproteinA-IV gene and plasma lipid response to envergy restricted diets in overweight subjects. Atherosclerosis 150: 187-192, 2000.
42. Kretowski A, Hokanson JE, McFann K, Kinney GL, Snell-Bergeon JK, Maahs DM, Wadwa RP, Eckel RH, Ogden LG and Garg SK: The apolipoprotein A-IV Gln360His polymorphism predicts progression of coronary artery calcification in patients with type 1 diabetes. Diabetologia 49: 1946-1954, 2006.
43. Antoine HJ, Pall M, Trader BC, Chen YD, Azziz R and Goodarzi MO: Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome. Fertil Steril 87: 862-869, 2007.
44. Codner E and Cassorla F: Puberty and ovarian function in girls with type 1 diabetes mellitus. Horm Res 71: 12-21, 2009.
45. Tsanadis G, Vartholomatos G, Korkontzelos I, Avgoustatos F, Kakosimos G, Sotiriadis A, Tatsioni A, Eleftheriou A and Lolis D: Polycystic ovarian syndrome and thrombophilia. Hum Reprod 17: 314-319, 2002.
46. Atiomo WU, Bates SA, Condon JE, Shaw S, West JH and Prentice AG: The plasminogen activator system in women with polycystic ovary syndrome. Fertil Steril 69: 236-241, 1998.
47. Dahlgren E, Janson PO, Johansson S, Lapidus L, Lindstedt G and Tengborn L: Hemostatic and metabolic variables in women with polycystic ovary syndrome. Fertil Steril 61: 455-460, 1994.
48. Kelly CJ, Lyall H, Petrie JR, Gould GW, Connell JM, Rumley A, Lowe GD and Sattar N: A specific elevation in tissue plasminogen activator antigen in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 87: 3287-3290, 2002.